Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome

V Fremeaux-Bacchi, MA Dragon-Durey… - Journal of medical …, 2004 - jmg.bmj.com
V Fremeaux-Bacchi, MA Dragon-Durey, J Blouin, C Vigneau, D Kuypers, B Boudailliez…
Journal of medical genetics, 2004jmg.bmj.com
METHODS Patients The subjects in this study were patients attending departments of
paediatric and adult nephrology and departments of internal medicine in several university
hospitals in France and Belgium over a period of 3 years. All participants provided informed
consent. The clinical work out was performed in each referring centre. Twenty five patients
(15 children and 10 adults) with atypical HUS and no factor H mutation were studied. Six of
the patients had a familial variant of HUS (at least two siblings with the disease) and six …
METHODS Patients The subjects in this study were patients attending departments of paediatric and adult nephrology and departments of internal medicine in several university hospitals in France and Belgium over a period of 3 years. All participants provided informed consent. The clinical work out was performed in each referring centre. Twenty five patients (15 children and 10 adults) with atypical HUS and no factor H mutation were studied. Six of the patients had a familial variant of HUS (at least two siblings with the disease) and six exhibited persistent mild alternative pathway complement consumption with low C3 levels. Nineteen patients presented a sporadic, atypical form of HUS.
Case reports Patient 1, a 32 year old Caucasian woman (P1), after pregnancy developed acute renal failure, hypertension, and haemolytic anaemia of rapid onset. Renal biopsy disclosed a pattern of thrombotic microangiopathy predominantly in the glomeruli, with few vascular lesions. HUS recurred 2 and 4 months later with partial renal function recovery but
jmg.bmj.com